AU2010225405B2 - Transdermal pharmaceutical preparation and administration of tirofiban - Google Patents

Transdermal pharmaceutical preparation and administration of tirofiban Download PDF

Info

Publication number
AU2010225405B2
AU2010225405B2 AU2010225405A AU2010225405A AU2010225405B2 AU 2010225405 B2 AU2010225405 B2 AU 2010225405B2 AU 2010225405 A AU2010225405 A AU 2010225405A AU 2010225405 A AU2010225405 A AU 2010225405A AU 2010225405 B2 AU2010225405 B2 AU 2010225405B2
Authority
AU
Australia
Prior art keywords
tirofiban
delivery system
drug delivery
transdermal
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010225405A
Other languages
English (en)
Other versions
AU2010225405A1 (en
Inventor
Albert D. Friesen
Dawson James Reimer
George Roby Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicure International Inc
Original Assignee
Medicure International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicure International Inc filed Critical Medicure International Inc
Publication of AU2010225405A1 publication Critical patent/AU2010225405A1/en
Application granted granted Critical
Publication of AU2010225405B2 publication Critical patent/AU2010225405B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
    • A61F13/0253—Adhesive bandages or dressings characterised by the skin-adhering layer characterized by the adhesive material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2010225405A 2009-03-18 2010-03-18 Transdermal pharmaceutical preparation and administration of tirofiban Ceased AU2010225405B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16113209P 2009-03-18 2009-03-18
US61/161,132 2009-03-18
US24002109P 2009-09-04 2009-09-04
US61/240,021 2009-09-04
US25968309P 2009-11-10 2009-11-10
US61/259,683 2009-11-10
PCT/CA2010/000373 WO2010105342A1 (en) 2009-03-18 2010-03-18 Transdermal pharmaceutical preparation and administration of tirofiban

Publications (2)

Publication Number Publication Date
AU2010225405A1 AU2010225405A1 (en) 2011-11-10
AU2010225405B2 true AU2010225405B2 (en) 2014-10-23

Family

ID=42739074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010225405A Ceased AU2010225405B2 (en) 2009-03-18 2010-03-18 Transdermal pharmaceutical preparation and administration of tirofiban

Country Status (9)

Country Link
US (2) US20120029447A1 (cg-RX-API-DMAC10.html)
EP (1) EP2408440B1 (cg-RX-API-DMAC10.html)
JP (2) JP2012520829A (cg-RX-API-DMAC10.html)
CN (2) CN102427806B (cg-RX-API-DMAC10.html)
AU (1) AU2010225405B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI1009313A2 (cg-RX-API-DMAC10.html)
CA (1) CA2755569A1 (cg-RX-API-DMAC10.html)
RU (1) RU2539398C2 (cg-RX-API-DMAC10.html)
WO (1) WO2010105342A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114984330A (zh) * 2022-06-07 2022-09-02 新乡医学院 一种兼具抗凝与抗钙化的脱细胞血管支架及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117842A (en) * 1998-03-09 2000-09-12 Merck & Co., Inc. Fibrinogen receptor antagonists
US7220473B2 (en) * 2000-12-06 2007-05-22 Hexal Ag Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271940A (en) * 1989-09-14 1993-12-21 Cygnus Therapeutic Systems Transdermal delivery device having delayed onset
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US20040072750A1 (en) * 2001-05-03 2004-04-15 David Phillips Compounds and methods for the modulation of CD154
US6770660B2 (en) * 2002-05-06 2004-08-03 Artery Llc Method for inhibiting platelet aggregation
US20050019742A1 (en) * 2002-10-15 2005-01-27 Jennings Lisa K. Methods for assessment of platelet aggregation
AR049847A1 (es) * 2004-07-29 2006-09-06 Merck & Co Inc Inhibidores de los canales de potasio

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117842A (en) * 1998-03-09 2000-09-12 Merck & Co., Inc. Fibrinogen receptor antagonists
US7220473B2 (en) * 2000-12-06 2007-05-22 Hexal Ag Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system

Also Published As

Publication number Publication date
CN102427806A (zh) 2012-04-25
CN102427806B (zh) 2015-11-25
BRPI1009313A2 (pt) 2018-01-30
US20140100537A1 (en) 2014-04-10
WO2010105342A1 (en) 2010-09-23
CN105311003A (zh) 2016-02-10
JP2012520829A (ja) 2012-09-10
EP2408440B1 (en) 2016-05-11
AU2010225405A1 (en) 2011-11-10
RU2539398C2 (ru) 2015-01-20
US20120029447A1 (en) 2012-02-02
RU2011138305A (ru) 2013-03-27
EP2408440A1 (en) 2012-01-25
EP2408440A4 (en) 2013-10-09
JP2015187115A (ja) 2015-10-29
CA2755569A1 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
CN105431175B (zh) 透皮递送系统
EP1814531B1 (en) Transdermal delivery systems
JP2003511425A (ja) 二元粘着性経皮薬物デリバリーシステム
PT1589956E (pt) Granisetron transdérmico
JP4624978B2 (ja) 血小板血症治療用製剤および治療方法
EP2408440B1 (en) Transdermal pharmaceutical preparation and administration of tirofiban
Jose et al. Recent progress of transdermal drug delivery systems for biomedical applications
TW200840599A (en) Transdermal method and patch for corticosteroid administration
CN110115710B (zh) 一种用于治疗哮喘的透皮吸收制剂
Kumar et al. A review on transdermal drug delivery patches
Macit et al. Steam bath, vibration, and thermal ablation administrations augment the release of tramadol HCl from transdermal patch and enhance the plasma concentration in rats
US7323191B2 (en) Transdermal warfarin system
Nikitha et al. Advancements in Transdermal Drug Delivery System
US20230390215A1 (en) Systems, devices, and formulations for time-phased histamine delivery
JP2025096518A (ja) 酸化防止剤含有経皮吸収製剤
JP2019034905A (ja) デヒドロ酢酸含有経皮吸収製剤
Ibhrahimpatnam et al. TRANSDERMAL DRUG DELIVERY SYSTEMS
WO2007121949A1 (en) Transdermal delivery system comprising sufentanil and its analogues
BChir et al. Transdermal drug delivery in pain management
Rahman et al. A Review on Trasdermal Patch and Marketed Preparations
Karthikeyan et al. TRANSDERMAL DRUG DELIVERY SYSTEM-A NON INVASIVE WAY OF DRUG ADMINISTRATION
PC et al. International Journal of Modern Pharmaceutical Research
JP2012520829A5 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired